These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25252227)

  • 1. Oral fingolimod to treat multiple sclerosis: see your cardiologist first.
    Sato DK; Callegaro D
    Arq Neuropsiquiatr; 2014 Sep; 72(9):651-2. PubMed ID: 25252227
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumefactive multiple sclerosis and fingolimod.
    Lovera J; Villemarette-Pittman N
    J Neurol Sci; 2014 Sep; 344(1-2):1-2. PubMed ID: 24993468
    [No Abstract]   [Full Text] [Related]  

  • 3. Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.
    Castillo-Trivino T; Lopetegui I; Alarcón-Duque JA; López de Munain A; Olascoaga J
    J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):931-2. PubMed ID: 25835036
    [No Abstract]   [Full Text] [Related]  

  • 4. [A plan for risk management in the treatment of multiple sclerosis with gilenia (fingolimod)].
    Popova NF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):110-3. PubMed ID: 21916166
    [No Abstract]   [Full Text] [Related]  

  • 5. The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis.
    Fragoso YD; Arruda CC; Arruda WO; Brooks JB; Damasceno A; Damasceno CA; Finkelsztejn A; Finkelsztejn J; Gama PD; Giacomo MC; Gomes S; Goncalves MV; Matta AP; de Morais MM; Oliveira EM; Ribeiro Y; Sato HK; Tauil CB
    Arq Neuropsiquiatr; 2014 Sep; 72(9):712-4. PubMed ID: 25252236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pill times 2: what every woman with multiple sclerosis should know.
    Langer-Gould AM
    Neurology; 2014 Feb; 82(8):654-5. PubMed ID: 24463629
    [No Abstract]   [Full Text] [Related]  

  • 7. Fingolimod: cardiovascular deaths.
    Prescrire Int; 2012 Apr; 21(126):99. PubMed ID: 22515137
    [No Abstract]   [Full Text] [Related]  

  • 8. New drugs may improve, complicate treatment for multiple sclerosis.
    Link H; Martin R
    Nat Med; 2010 Mar; 16(3):272. PubMed ID: 20208513
    [No Abstract]   [Full Text] [Related]  

  • 9. Trial watch: Phase III promise for oral multiple sclerosis therapy.
    Nat Rev Drug Discov; 2009 Feb; 8(2):98. PubMed ID: 19180099
    [No Abstract]   [Full Text] [Related]  

  • 10. Fingolimod and multiple sclerosis: four cautionary tales.
    Bourdette D; Gilden D
    Neurology; 2012 Nov; 79(19):1942-3. PubMed ID: 23035058
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient.
    Lysandropoulos AP; Benghiat F
    Mult Scler; 2013 Oct; 19(11):1551-2. PubMed ID: 23817558
    [No Abstract]   [Full Text] [Related]  

  • 12. Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report.
    Conzett KB; Kolm I; Jelcic I; Kamarachev J; Dummer R; Braun R; French LE; Linnebank M; Hofbauer GF
    Arch Dermatol; 2011 Aug; 147(8):991-2. PubMed ID: 21844470
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral fingolimod (gilenya) for multiple sclerosis.
    Med Lett Drugs Ther; 2010 Dec; 52(1353-1354):98-9. PubMed ID: 21344782
    [No Abstract]   [Full Text] [Related]  

  • 14. Cystoid macular edema associated with fingolimod use for multiple sclerosis.
    Afshar AR; Fernandes JK; Patel RD; Ksiazek SM; Sheth VS; Reder AT; Hariprasad SM
    JAMA Ophthalmol; 2013 Jan; 131(1):103-7. PubMed ID: 23307220
    [No Abstract]   [Full Text] [Related]  

  • 15. Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment.
    Rolf L; Muris AH; Damoiseaux J; van Daele M; Hupperts R
    Neurology; 2014 Mar; 82(11):1008-9. PubMed ID: 24523479
    [No Abstract]   [Full Text] [Related]  

  • 16. [FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis].
    Klatt J; Hartung HP; Hohlfeld R
    Nervenarzt; 2007 Oct; 78(10):1200-8. PubMed ID: 17668161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fingolimod for multiple sclerosis.
    Pelletier D; Hafler DA
    N Engl J Med; 2012 Jan; 366(4):339-47. PubMed ID: 22276823
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed fingolimod-associated asystole.
    Espinosa PS; Berger JR
    Mult Scler; 2011 Nov; 17(11):1387-9. PubMed ID: 21652609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Branch retinal vein occlusion during fingolimod treatment in a patient with multiple sclerosis.
    Gallego-Pinazo R; España-Gregori E; Casanova B; Pardo-López D; Díaz-Llopis M
    J Neuroophthalmol; 2011 Sep; 31(3):292-3. PubMed ID: 21826025
    [No Abstract]   [Full Text] [Related]  

  • 20. [New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimod].
    Komoly S
    Ideggyogy Sz; 2012 Nov; 65(11-12):421-2. PubMed ID: 23289178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.